Bionik Laboratories Corp. Annual Share-based Payment Arrangement, Expense in USD from 2012 to 2022

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Bionik Laboratories Corp. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2012 to 2022.
  • Bionik Laboratories Corp. Share-based Payment Arrangement, Expense for the quarter ending March 31, 2023 was $114K, a 42.5% increase year-over-year.
  • Bionik Laboratories Corp. Share-based Payment Arrangement, Expense for the twelve months ending March 31, 2023 was $300K, a 25% decline year-over-year.
  • Bionik Laboratories Corp. annual Share-based Payment Arrangement, Expense for 2022 was $300K, a 25% decline from 2021.
  • Bionik Laboratories Corp. annual Share-based Payment Arrangement, Expense for 2021 was $400K, a 50% decline from 2020.
  • Bionik Laboratories Corp. annual Share-based Payment Arrangement, Expense for 2020 was $800K, a 52.9% decline from 2019.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2022 $300K -$100K -25% Apr 1, 2022 Mar 31, 2023 10-K 2023-06-21
2021 $400K -$400K -50% Apr 1, 2021 Mar 31, 2022 10-K 2023-06-21
2020 $800K -$900K -52.9% Apr 1, 2020 Mar 31, 2021 10-K 2022-06-09
2019 $1.7M +$1.56M +1110% Apr 1, 2019 Mar 31, 2020 10-K 2021-06-24
2018 $141K +$113K +415% Apr 1, 2018 Mar 31, 2019 10-K 2020-06-30
2017 $27.3K Apr 1, 2017 Mar 31, 2018 10-K 2019-07-01
2013 $0 -$117K -100% Apr 1, 2013 Mar 31, 2014 10-KT 2015-05-27
2012 $117K Apr 1, 2012 Mar 31, 2013 10-KT 2015-05-27
* An asterisk sign (*) next to the value indicates that the value is likely invalid.